Stocks · Korea 263050 KOSDAQ

Eutilex

959원 +0.00% Market cap 353억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR2.31x
EPS0 KRW
BPS415 KRW
ROE-184.23%
DPS0 KRW

Returns and 52-week range

1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y-44.18%
YTD-10.87%
52W high1,673원
52W low—
From 52W high-42.68%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20220원-367억-345억—
20230원-298억-283억—
202495억-265억-295억-278.3%
2025103억-189억-258억-183.8%
Quarterly
2024 4Q30억-76억-111억-258.0%
2025 1Q20억-48억-48억-236.3%
2025 2Q23억-52억-39억-224.4%
2025 3Q35억-38억-39억-108.6%
2025 4Q24억-50억-131억-210.5%
2026 1Q13억-26억-27억-206.7%

Company

CEO권병세, 안용섭 (각자대표이사)
Founded2015-02-27
Fiscal year end12
Address: 서울특별시 금천구 가산디지털1로 58 408호 (가산동, 에이스한솔타워)

Peers in the same sector

CompanyMarket capP/EP/B1M
알리코제약362억—0.45-4.44%
고려제약353억5.330.42-8.29%
하스413억26.030.89+2.20%
비씨월드제약324억—0.43-0.16%
원바이오젠425억6.420.99-2.92%
티디에스팜310억6.930.69-3.78%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.